148 related articles for article (PubMed ID: 29704266)
1. The role of interleukins in vitiligo: a systematic review.
Gomes IA; de Carvalho FO; de Menezes AF; Almeida FM; Shanmugam S; de Souza Siqueira Quintans J; Quintans-Júnior LJ; de Moura TR; Oliveira PD; de Souza Araújo AA
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2097-2111. PubMed ID: 29704266
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 affects cytokine production by keratinocytes in vitiligo.
Li P; Ma H; Han D; Mou K
Clin Exp Dermatol; 2015 Mar; 40(2):163-70. PubMed ID: 25251808
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients.
Elela MA; Hegazy RA; Fawzy MM; Rashed LA; Rasheed H
Eur J Dermatol; 2013; 23(3):350-5. PubMed ID: 23797460
[TBL] [Abstract][Full Text] [Related]
4. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17 level in patients with vitiligo: A systematic review and meta-analysis.
Acharya P; Mathur M
Australas J Dermatol; 2020 May; 61(2):e208-e212. PubMed ID: 31895472
[TBL] [Abstract][Full Text] [Related]
6. The role of cytokines and vitamin D in vitiligo pathogenesis.
Beyzaee AM; Goldust M; Patil A; Rokni GR; Beyzaee S
J Cosmet Dermatol; 2022 Nov; 21(11):6314-6325. PubMed ID: 35871394
[TBL] [Abstract][Full Text] [Related]
7. Neuronal cell survival: the role of interleukins.
de Araujo EG; da Silva GM; Dos Santos AA
Ann N Y Acad Sci; 2009 Feb; 1153():57-64. PubMed ID: 19236328
[TBL] [Abstract][Full Text] [Related]
8. [Cytokines in allergic inflammatory process].
Rutkowski R; Moniuszko T
Postepy Hig Med Dosw; 2001; 55(4):587-603. PubMed ID: 11766232
[TBL] [Abstract][Full Text] [Related]
9. Correlations of IL-6, IL-8, IL-10, IL-17 and TNF-α with the pathological stage and prognosis of glioma patients.
Zhan X; Gao H; Sun W
Minerva Med; 2020 Apr; 111(2):192-195. PubMed ID: 31124633
[No Abstract] [Full Text] [Related]
10. Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.
Bhardwaj S; Rani S; Srivastava N; Kumar R; Parsad D
Cytokine; 2017 Mar; 91():153-161. PubMed ID: 28082234
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Cytokines and Proliferation Marker Ki67 in Cleft Affected Lip Tissue.
Pilmane M; Sidhoma E; Akota I; Kazoka D
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31443525
[No Abstract] [Full Text] [Related]
12. The role of interleukin-33 in chronic rhinosinusitis.
Kim DK; Jin HR; Eun KM; Mo JH; Cho SH; Oh S; Cho D; Kim DW
Thorax; 2017 Jul; 72(7):635-645. PubMed ID: 27885166
[TBL] [Abstract][Full Text] [Related]
13. The Role of Interleukin-19 in Contact Hypersensitivity.
Fujimoto Y; Fujita T; Kuramoto N; Kuwamura M; Izawa T; Nishiyama K; Yoshida N; Nakajima H; Takeuchi T; Azuma YT
Biol Pharm Bull; 2018; 41(2):182-189. PubMed ID: 29386478
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.
Petra AI; Tsilioni I; Taracanova A; Katsarou-Katsari A; Theoharides TC
Allergy Asthma Proc; 2018 Mar; 39(2):153-160. PubMed ID: 29490771
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
[TBL] [Abstract][Full Text] [Related]
16. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T-cell cytokines in patients with nonsegmental vitiligo.
Kidir M; Karabulut AA; Ercin ME; Atasoy P
Int J Dermatol; 2017 May; 56(5):581-588. PubMed ID: 28247923
[TBL] [Abstract][Full Text] [Related]
18. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver.
Xiang X; Gui H; King NJ; Cole L; Wang H; Xie Q; Bao S
Immunol Cell Biol; 2012 Jul; 90(6):611-9. PubMed ID: 21946664
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
Grimes PE; Morris R; Avaniss-Aghajani E; Soriano T; Meraz M; Metzger A
J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
[TBL] [Abstract][Full Text] [Related]
20. Expression of IL-33 in the epidermis: The mechanism of induction by IL-17.
Meephansan J; Komine M; Tsuda H; Karakawa M; Tominaga S; Ohtsuki M
J Dermatol Sci; 2013 Aug; 71(2):107-14. PubMed ID: 23764374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
